These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 1336913)

  • 1. [The EBNA2 coding region in the viral genome of Epstein-Barr virus (EBV)-positive cases of Hodgkin's disease].
    Borisch B; Telenti A; Hennig I; Marchesi F; Audouin J; Diebold J; Pallesen G
    Verh Dtsch Ges Pathol; 1992; 76():181-4. PubMed ID: 1336913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of the expression of Epstein-Barr virus latent membrane protein and in situ hybridization with biotinylated BamHI-W probes in Hodgkin's disease.
    Delsol G; Brousset P; Chittal S; Rigal-Huguet F
    Am J Pathol; 1992 Feb; 140(2):247-53. PubMed ID: 1310829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression of latent membrane proteins (LMP) of Epstein-Barr virus in malignant lymphomas].
    Herbst H; Dallenbach F; Niedobitek G; Anagnostopoulos I; Hummel M; Finn T; Jautzke G; Müller-Lantzsch N; Stein H
    Verh Dtsch Ges Pathol; 1991; 75():175-8. PubMed ID: 1724825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the methods for the detection of Epstein-Barr virus nucleic acids and related gene products in Hodgkin's disease.
    Brousset P; Meggetto F; Chittal S; Bibeau F; Arnaud J; Rubin B; Delsol G
    Lab Invest; 1993 Oct; 69(4):483-90. PubMed ID: 8231115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus infection and associated products (LMP, EBNA2, vIL-10) in nodal non-Hodgkin's lymphoma of human immunodeficiency virus-negative Japanese.
    Ohshima K; Suzumiya J; Tasiro K; Mukai Y; Tanaka T; Kato A; Kikuchi M
    Am J Hematol; 1996 May; 52(1):21-8. PubMed ID: 8638607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
    Leong IT; Fernandes BJ; Mock D
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-existence of the A and B types of Epstein-Barr virus DNA in lymph node biopsies from Algerian patients with Hodgkin's disease and non-Hodgkin's lymphoma.
    Bouzid M; Belkaid MI; Colonna P; Bouguermouh AM; Ooka T
    Leukemia; 1993 Sep; 7(9):1451-5. PubMed ID: 8396698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency.
    Hamilton-Dutoit SJ; Rea D; Raphael M; Sandvej K; Delecluse HJ; Gisselbrecht C; Marelle L; van Krieken HJ; Pallesen G
    Am J Pathol; 1993 Oct; 143(4):1072-85. PubMed ID: 8214003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent expression of Epstein-Barr virus latent membrane protein-1 in tumour cells of Hodgkin's disease in HIV-positive patients.
    Audouin J; Diebold J; Pallesen G
    J Pathol; 1992 Aug; 167(4):381-4. PubMed ID: 1328576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus in B-cell non-Hodgkin's lymphomas: unexpected infection patterns and different infection incidence in low- and high-grade types.
    Hummel M; Anagnostopoulos I; Korbjuhn P; Stein H
    J Pathol; 1995 Mar; 175(3):263-71. PubMed ID: 7745495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens.
    Masucci G; Mellstedt H; Masucci MG; Szigeti R; Ernberg I; Björkholm M; Tsukuda K; Henle G; Henle W; Pearson G
    Cancer Res; 1984 Mar; 44(3):1288-300. PubMed ID: 6318984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of Epstein-Barr virus in Hodgkin-Reed-Sternberg cells : no evidence for the persistence of integrated viral fragments inLatent membrane protein-1 (LMP-1)-negative classical Hodgkin's disease.
    Staratschek-Jox A; Kotkowski S; Belge G; Rüdiger T; Bullerdiek J; Diehl V; Wolf J
    Am J Pathol; 2000 Jan; 156(1):209-16. PubMed ID: 10623669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High incidence of EBV genome in CD30-positive non-Hodgkin's lymphomas.
    Kanavaros P; Jiwa NM; de Bruin PC; van der Valk P; Noorduyn LA; van Heerde P; Gordijn R; Horstman A; Mullink R; Willemze R
    J Pathol; 1992 Nov; 168(3):307-15. PubMed ID: 1335046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Epstein-Barr virus and malignant lymphomas--studies on incidence and localization of viral DNA].
    Herbst H; Niedobitek G; Anagnostopoulos I; Hummel M; Finn T; Bergholz M; Kneba M; Krieger G; Stein H
    Verh Dtsch Ges Pathol; 1990; 74():386-9. PubMed ID: 1708622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence of Epstein-Barr virus genome on patient survival in Hodgkin's disease].
    Niedermeyer H; Fellbaum C; Hansmann ML; Kraus I; Alavaikko MJ; Busch R; Pütz B; Fischer R; Höfler H
    Verh Dtsch Ges Pathol; 1992; 76():173-6. PubMed ID: 1283253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical detection of Epstein-Barr virus-encoded latent membrane protein in Reed-Sternberg cells and variants of Hodgkin's disease.
    Pinkus GS; Lones M; Shintaku IP; Said JW
    Mod Pathol; 1994 May; 7(4):454-61. PubMed ID: 7520586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Epstein-Barr virus replicative proteins in AIDS-related non-Hodgkin's lymphoma cells.
    Pallesen G; Hamilton-Dutoit SJ; Rowe M; Lisse I; Ralfkiaer E; Sandvej K; Young LS
    J Pathol; 1991 Dec; 165(4):289-99. PubMed ID: 1664459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent detection of Epstein-Barr viral deoxyribonucleic acid and absence of cytomegalovirus deoxyribonucleic acid in Hodgkin's disease and acquired immunodeficiency syndrome-related Hodgkin's disease.
    Samoszuk M; Ravel J
    Lab Invest; 1991 Dec; 65(6):631-6. PubMed ID: 1661351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral and cellular factors influence the activity of the Epstein-Barr virus BCR2 and BWR1 promoters in cells of different phenotype.
    Nilsson T; Sjöblom A; Masucci MG; Rymo L
    Virology; 1993 Apr; 193(2):774-85. PubMed ID: 8384755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus infection and bcl-2 proto-oncogene expression. Separate events in the pathogenesis of Hodgkin's disease?
    Khan G; Gupta RK; Coates PJ; Slavin G
    Am J Pathol; 1993 Nov; 143(5):1270-4. PubMed ID: 8238244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.